07/08/2025
3:10 PM | Rapt Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2025
7:41 PM | Dombkowski Ashley L. (Reporting)
Rapt Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/30/2025
7:43 PM | Dombkowski Ashley L. (Reporting)
Rapt Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2025
3:23 PM | Braunstein Scott (Reporting)
Rapt Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/24/2025
3:25 PM | Braunstein Scott (Reporting)
Rapt Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
7:10 AM | Rapt Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2025
7:11 AM | Rapt Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/09/2025
3:20 PM | Rapt Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2025
4:02 PM | Lyons-Williams Lori (Reporting)
Rapt Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
4:04 PM | GRAY MARY ANN (Reporting)
Rapt Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2025
4:06 PM | Giordano Michael F (Reporting)
Rapt Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RAPT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Rapt Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/29/2025
3:30 PM | Rapt Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
7:00 AM | Rapt Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SCHEDULE 13G | |
05/08/2025
7:05 AM | Rapt Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
7:07 AM | Rapt Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2025
5:35 PM | BlackRock, Inc. (Filed by)
Rapt Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/14/2025
7:35 AM | Rapt Therapeutics (Filer)
| Form DEF 14A | |
04/14/2025
7:38 AM | Rapt Therapeutics (Filer)
| Form DEFA14A | |
04/04/2025
4:04 PM | Rapt Therapeutics (Filer)
| Form PRE 14A | |
04/02/2025
8:08 PM | Rapt Therapeutics (Issuer)
Robbins Wendye (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
7:40 PM | GRAY MARY ANN (Reporting)
Rapt Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
8:04 AM | Rapt Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/06/2025
7:05 AM | Rapt Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
7:07 AM | Rapt Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
7:02 PM | Rapt Therapeutics (Subject)
Redmile Group, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
4:31 PM | Rapt Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
4:31 PM | Rapt Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G/A | |
02/07/2025
9:23 AM | FMR LLC (Filed by)
Rapt Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/03/2025
5:22 PM | Rapt Therapeutics (Issuer)
Wong Brian Russell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
5:23 PM | Brockstedt Dirk G. (Reporting)
Rapt Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
5:24 PM | Rapt Therapeutics (Issuer)
Young Rodney KB (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2025
5:26 PM | HO WILLIAM (Reporting)
Rapt Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
6:35 AM | Rapt Therapeutics (Filer)
| Form 424B3 | |
01/27/2025
11:15 PM | Rapt Therapeutics (Filer)
| Form EFFECT | |
01/21/2025
3:58 PM | Rapt Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/13/2025
3:17 PM | Rapt Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
5:38 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Rapt Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/06/2025
8:22 AM | Medicxi IV LP (Filed by)
Rapt Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/06/2025
8:12 AM | Medicxi Co-Invest IV LP (Reporting)
Medicxi IV GP Ltd (Reporting)
Medicxi IV LP (Reporting)
Medicxi Ventures Management Ltd (0001715579) (Reporting)
Rapt Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/03/2025
1:08 PM | Rapt Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/30/2024
2:32 PM | Foresite Capital Fund VI LP (Filed by)
Rapt Therapeutics (Subject)
| Form SCHEDULE 13G | |
The End of Elon Musk…? (Ad) The End of Elon Musk? Don't make him laugh.
Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again.
And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again.
According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime. Click here to see why the "End of Elon" crowd is about to be wrong again. |
12/23/2024
7:20 PM | COLUMN GROUP II, LP (Filed by)
Rapt Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
12/23/2024
4:57 PM | Column Group II GP, LP (Reporting)
COLUMN GROUP II, LP (Reporting)
Column Group LLC (Reporting)
GOEDDEL DAVID V (Reporting)
Kutzkey Tim (Reporting)
Ponoi Capital II, LP (Reporting)
PONOI CAPITAL, LP (Reporting)
Ponoi II Management, LLC (Reporting)
Ponoi Management, LLC (Reporting)
Rapt Therapeutics (Issuer)
Svennilson Peter (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
4:59 PM | COLUMN GROUP II, LP (Reporting)
Column Group IV GP, LP (Reporting)
Column Group IV, LP (Reporting)
Column Group IV-A, LP (Reporting)
Rapt Therapeutics (Issuer)
TCG IV GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:55 PM | Rapt Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
3:42 PM | Deep Track Capital, LP (Filed by)
Rapt Therapeutics (Subject)
| Form SCHEDULE 13G | |
12/23/2024
6:16 AM | Rapt Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
7:00 PM | Brockstedt Dirk G. (Reporting)
Rapt Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
7:00 PM | HO WILLIAM (Reporting)
Rapt Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
7:00 PM | Rapt Therapeutics (Issuer)
Wong Brian Russell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
7:00 PM | Rapt Therapeutics (Issuer)
Young Rodney KB (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
4:15 PM | Rapt Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
8:39 AM | Deep Track Capital, LP (Filed by)
Rapt Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
3:59 PM | Rapt Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Rapt Therapeutics (Subject)
| Form SC 13G/A | |
11/04/2024
12:30 PM | Rapt Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
08/08/2024
7:05 AM | Rapt Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
7:10 AM | Rapt Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/19/2024
4:24 PM | Rapt Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
